首页> 美国卫生研究院文献>Molecular and Clinical Oncology >Comprehensive treatment of unresectable cardiac angiosarcoma: A case report and review of literature
【2h】

Comprehensive treatment of unresectable cardiac angiosarcoma: A case report and review of literature

机译:不能切除的心脏血管肉瘤的综合治疗:一例报告并文献复习

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cardiac angiosarcoma is a rare but lethal tumor that is difficult to diagnose and treat, due to its rapid local relapse and high incidence of systemic metastasis. The prognosis of cardiac angiosarcoma is dismal, with a mean life expectancy of only a few months. We herein report a case of unresectable angiosarcoma arising from the right atrium. The patient received first-line chemotherapy with weekly paclitaxel, and second-line therapy with vinorelbine and bevacizumab upon disease progression. The progression-free survival was 6 months and the overall survival was 7 months. The patient eventually succumbed to respiratory failure. A study of the present case and a review of the relevant literature suggest that treatment decisions for unresectable locally advanced or metastatic cardiac angiosarcoma are difficult, as the published literature on this disease mainly consists of case reports without sufficient data. Therefore, further clinical trials specific to the treatment of unresectable cardiac angiosarcoma are warranted.
机译:心脏血管肉瘤是一种罕见但致命的肿瘤,由于其快速的局部复发和高系统转移率,因此难以诊断和治疗。心脏血管肉瘤的预后很差,平均预期寿命只有几个月。我们在此报告了由右房引起的不可切除的血管肉瘤病例。患者在疾病进展时接受每周紫杉醇的一线化疗和长春瑞滨和贝伐单抗的二线治疗。无进展生存期为6个月,总生存期为7个月。病人最终屈服于呼吸衰竭。对本病例的研究和对相关文献的回顾表明,对于不可切除的局部晚期或转移性心脏血管肉瘤的治疗决策是困难的,因为有关该病的已发表文献主要包括病例报告,但没有足够的数据。因此,有必要针对无法手术的心脏血管肉瘤进行进一步的临床试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号